Get started
Author

R. A. Murashko

Observed names: R.A. Murashko, R.  A. Murashko, Р А Мурашко, Р. А. Мурашко, Р.А. Мурашко, Роман Мурашко
ORCID: 0000-0001-8084-8770
Observed ORCID: 0000-0001-8084-8770
OpenAlex ID: A5065954156
Topical issues of chemoradiotherapy for oropharyngeal squamous cell carcinoma: the efficiency and toxicity of chemotherapy regimens with the goal of radiomodification
2018 · A. I. Stukan, R. A. Murashko, et al. · P A Herzen Journal of Oncology · 4
Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender
2022 · A. I. Stukan, R.  A. Murashko, et al. · Head and neck tumors (HNT) · 3
PDF
Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy
2024 · E. A. Nikolaeva, A. S. Krylov, et al. · Cancer Urology · 2
PDF
Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy
2022 · A. I. Stukan, A. Yu. Goryainova, et al. · Bulletin of Siberian Medicine · 2
Clinical, morphological, and prognostic features of head and neck squamous cell carcinoma associated with human papillomavirus
2019 · A. I. Stukan, O. Yu. Chukhray, et al. · P A Herzen Journal of Oncology · 2
Principles of Building an Effective Regional Multilevel Model of Oncological Care
2026 · M.Yu. Mostovoy, R.A. Murashko, et al. · Effective Pharmacotherapy · 1
PDF
Robot-assisted surgery for rectal cancer in patients after neoadjuvant chemoradiotherapy Immediate results
2024 · M. E. Moiseev, V. N. Kotiv, et al. · Surgery and Oncology · 1
PDF
The Average Age of Cancer Diagnosis in the Krasnodar Territory (According to the Population Cancer Registry Krasnodar Region)
2023 · R.A. Murashko, L.G. Teslenko, et al. · Effective Pharmacotherapy · 1
Effect of Differences in the Expression Levels Steroid Hormone Receptors and HER2 in the Primary Tumor and Metastatic Focus on the Efficacy of Eribulin Monotherapy in Metastatic Breast Cancer
2023 · Анастасия Стукань, Роман Мурашко, et al. · Voprosy Onkologii · 1
PDF
Analysis of the regional clinical use of CDK4/6 inhibitor ribociclib as a mechanism of integration of a research approach in drug provision
2023 · A. Yu. Goryainova, R. A. Murashko, et al. · Meditsinskiy sovet = Medical Council · 1
PDF
Clinical and prognostic characteristics of BRCA1/2-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors
2022 · A. I. Stukan, A. Yu. Goryainova, et al. · Tumors of female reproductive system · 1
PDF
Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative breast cancer
2022 · A. Yu. Goryainova, A. I. Stukan, et al. · Meditsinskiy sovet = Medical Council · 1
Opportunities for reducing mortality from prostate cancer in Russia: analysis of data from the state cancer registry for 2018–2020
2022 · I. V. Laricheva, E. S. Yastrebova, et al. · Manager Zdravookhranenia · 1
Skin Melanoma and Ways to Improve Early Diagnosis of the Disease in Krasnodar Region
2019 · S.V. Sharov, M.G. Leonov, et al. · Effective Pharmacotherapy · 1
PDF
Клиническое Значение Определения Мутаций В Генах Braf И Nras В Опухолевой Ткани Пациентов С Меланомой Кожи
2026 · Ю.Ю. Стефанова, Н.В. Порханова, et al. · Современные проблемы науки и образования
PDF
Trastuzumab deruxtecan for the late lines of treatment for HER2-low metastatic breast cancer: a clinical case
2024 · R. A. Murashko, S. V. Sharov, et al. · Tumors of female reproductive system
New treatment options for HER2-positive metastatic breast cancer with leptomeningeal metastases
2024 · A. Yu. Goryainova, S. V. Sharov, et al. · Meditsinskiy sovet = Medical Council
Organization clinical decision-making programs in the local practice of the region: problematic issues that determine the choice of therapy in the progression of endometrial cancer
2023 · A. Yu. Goryainova, M. G. Leonov, et al. · Meditsinskiy sovet = Medical Council
PDF
Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitors
2021 · A. Yu. Goryainova, A. I. Stukan, et al. · Meditsinskiy sovet = Medical Council
PDF
Analysis of the clinical efficacy of the cyclin- dependent kinase inhibitor 4/6 Abemaciclib on the clinical case of a male with hormonereceptor- positive breast cancer
2021 · А. Y. Goryainova, А. I. Stukan, et al. · Meditsinskiy sovet = Medical Council
PDF
Disseminated Cutaneous Melanoma: Urgency of an Issue, Incidence, Treatment Perspective (literature Review)
2019 · R. A. Murashko, A. J. Goryainova, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Региональный Опыт Реализации Проекта «борьба С Онкологическими Заболеваниями»
2019 · Р А Мурашко, Л Л Степанова, et al. · Современные проблемы здравоохранения и медицинской статистики
Epidemiological Features of Melanoma Skin Cancer and Survival of Oncology Patients in Krasnodar Region
2018 · S. V. Sharov, R. A. Murashko, et al. · Кубанский научный медицинский вестник
PDF
Диссеминированная меланома кожи: актуальность проблемы, распространненость, перспективы лекарственного обеспечения
2016 · Р А Мурашко, А Ю Горяйнова, et al. · CyberLeninK (CyberLeninka)
Моделирование вклада от расширения практики применения ингибиторов циклинзависимых киназ 4 и 6 в снижение смертности населения от злокачественных новообразований
· Н. А. Авксентьев, E. В. Билан, et al. · CyberLeninK (CyberLeninka)
Works count: 25
Citation count: 22
H-index: 2
I10-index:
Year
Topic
Type